Rapid infectious disease test Xpert® SA

for genesStaphylococcus aureusMRSA

Up to 30% of the population is asymptomatically colonized with S. aureus1 S. aureus colonization is associated with an increased risk of severe infections, including surgical‑site and non‑surgical infections, which contribute to increased morbidity and mortality1 Perioperative therapeutic strategies vary depending on colonization of MRSA or MSSA2 The Solution SXpert SA Nasal Complete is a qualitative in vitro diagnostic test designed for the detection of S. aureus and methicillin-resistant S. aureus (MRSA) from nasal swabs in patients at risk for nasal colonization Identification of S. aureus nasal carriers can support implementation of infection control strategies The Impact Reliable detection of S. aureus and MRSA supports infection control and surveillance activities in healthcare settings4 Published studies have demonstrated that MRSA infections are associated with increased healthcare costs5 Minutes of hands-on time with results in about 1 hour on a random-access platform